These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11159752

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Late onset of CAD gene amplification in unamplified PALA resistant Chinese hamster mutants.
    Mucciolo E, Bertoni L, Mondello C, Giulotto E.
    Cancer Lett; 2000 Mar 31; 150(2):119-27. PubMed ID: 10704733
    [Abstract] [Full Text] [Related]

  • 6. The propensity for gene amplification: a comparison of protocols, cell lines, and selection agents.
    Sharma RC, Schimke RT.
    Mutat Res; 1994 Jan 16; 304(2):243-60. PubMed ID: 7506368
    [Abstract] [Full Text] [Related]

  • 7. Identification of additional complementation groups that regulate genomic instability.
    Hall IJ, Gioeli D, Weissman BE, Tlsty TD.
    Genes Chromosomes Cancer; 1997 Oct 16; 20(2):103-12. PubMed ID: 9331561
    [Abstract] [Full Text] [Related]

  • 8. Chromosome aberrations associated with CAD gene amplification in Chinese hamster cultured cells.
    Ottaggio L, Agnese C, Bonatti S, Cavolina P, De Ambrosis A, Degan P, Di Leonardo A, Miele M, Randazzo R, Abbondandolo A.
    Mutat Res; 1988 May 16; 199(1):111-21. PubMed ID: 2896299
    [Abstract] [Full Text] [Related]

  • 9. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.
    Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML, Stark GR.
    Mol Cell Biol; 1998 Jan 16; 18(1):536-45. PubMed ID: 9418900
    [Abstract] [Full Text] [Related]

  • 10. The presence of amplified regions affects the stability of chromosomes in drug-resistant Chinese hamster cells.
    Miele M, Bonatti S, Menichini P, Ottaggio L, Abbondandolo A.
    Mutat Res; 1989 May 16; 219(3):171-8. PubMed ID: 2567961
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of gene amplification in telomerase deficient immortalized mouse embryonic fibroblasts.
    Rebuzzini P, Martinelli P, Blasco M, Giulotto E, Mondello C.
    Carcinogenesis; 2007 Mar 16; 28(3):553-9. PubMed ID: 16973670
    [Abstract] [Full Text] [Related]

  • 14. Properties of single-step mutants of Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
    Zieg J, Clayton CE, Ardeshir F, Giulotto E, Swyryd EA, Stark GR.
    Mol Cell Biol; 1983 Nov 16; 3(11):2089-98. PubMed ID: 6656764
    [Abstract] [Full Text] [Related]

  • 15. DNA topoisomerase II inhibition and gene amplification in V79/B7 cells.
    Di Leonardo A, Cavolina P, Maddalena A.
    Mutat Res; 1993 Mar 16; 301(3):177-82. PubMed ID: 7679200
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 1-beta-D-arabinofuranosylcytosine enhancement of resistance to several antineoplastic drugs in mammalian tissue culture cells.
    Goz B, Carl PL, Tlsty TD.
    Mol Pharmacol; 1989 Sep 16; 36(3):360-5. PubMed ID: 2571071
    [Abstract] [Full Text] [Related]

  • 19. Structure of amplified DNA in different Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
    Ardeshir F, Giulotto E, Zieg J, Brison O, Liao WS, Stark GR.
    Mol Cell Biol; 1983 Nov 16; 3(11):2076-88. PubMed ID: 6656763
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.